Arg34GLP-1 (9-37) (H5) (Lyophilized Powder)

Skip to product information
1 of 1

Vazyme Biotech

SKU:JE3206L-00H

Regular price €59,00 EUR
Regular price Sale price €59,00 EUR
Sale Sold out
Taxes included. Shipping calculated at checkout.
Size
Quantity
View full details

Overview

Arg34GLP-1 (9-37) (H5) (Lyophilized Powder) is a research-use reagent supporting semaglutide intermediate peptide workflows. Semaglutide is a GLP-1 analog that can stimulate the human pancreas to secrete insulin and inhibit the secretion of glucagon, thereby achieving the goal of blood sugar control. The wording is kept close to the supplied product information, helping you reference the right item quickly and document consistently.

Key Benefits

  • High purityNo animal origin: Recombinant production, production process does not use any animal origin raw materials, and there is no external virus pollution.
  • Stable supply: Stable quality and batch production can ensure stable supply for semaglutide intermediate peptide documentation and method consistency.
  • Specification customization: The specifications can be customized according to customer needsComponents for semaglutide intermediate peptide documentation and method consistency.
  • Semaglutide is a GLP-1 analog that can stimulate the human pancreas to secrete insulin and inhibit the secretion of glucagon, thereby achieving the goal of blood.
  • This product is a biologically prepared semaglutide main chain, structured as an intermediate peptide composed of 29 amino acids.

How it supports your workflow

In day-to-day research, teams often need products that fit existing methods while remaining easy to justify in notes, SOPs, and reporting. For semaglutide intermediate peptide workflows, the goal is often to keep the scientific rationale and the purchasing record aligned. Semaglutide is a GLP-1 analog that can stimulate the human pancreas to secrete insulin and inhibit the secretion of glucagon, thereby achieving the goal of blood sugar control. This product is a biologically prepared semaglutide main chain, structured as an intermediate peptide composed of 29 amino acids. CAS NO:1169630-82-3 (Purity:≥98%). The supplied feature set highlights high purityno animal origin and stable supply, which can help teams standardize language and expectations across similar products. Because projects evolve, we aim for descriptions that remain searchable, specific, and easy to compare across catalog numbers—so you can reorder confidently and keep documentation consistent. Clear product wording is particularly helpful when you are comparing alternatives, standardizing across projects, or documenting why a specific catalog number was selected.

Applications & compatibility

Use the notes below to gauge fit for your setup and documentation needs. Based on the supplied information, it’s positioned for semaglutide intermediate peptide workflows where clear documentation and straightforward compatibility notes matter. If you’re matching this item to an established SOP, use the product name, catalog number, and the supplied features as the primary reference points. Use the application notes as a scope guide: they indicate fit and compatibility language drawn from the supplied product information, not assumptions beyond it.

Ideal for: labs focused on semaglutide intermediate peptide workflows; teams that need clear, searchable documentation for purchasing and experimental records; and groups standardizing methods across projects or sites. Ideal when you need a quick, confident match between what’s on the page and what’s in your records.

Storage Temperature:
-20°C

For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.

The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.